Top news
Oxford vaccine trial on hold because of potential safety issue
By Erika Edwards & Sara G. Miller
AstraZeneca CEO says participant had neurological symptoms, could be discharged today
By Adam Feuerstein
Safety Review Begins Into AstraZeneca's Coronavirus Vaccine Trial
By Katherine J. Wu
All coverage
Inside Oxford's Vaccine Saga: From Wild Hype to Sobering Reality
By Elizabeth Ralph
Oxford Vaccine: AstraZeneca Pauses Trial After Unexplained Illness
By Michelle Cortez & Riley Griffin
The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?
By Elias Visontay
The ethics of pausing a vaccine trial in the midst of a pandemic: a conversation with Ruth Faden
By Patrick J. Skerrett
AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
By Rebecca Robbins, Helen Branswell & Adam Feuerstein
AstraZeneca Pauses Vaccine Trial for Safety Review
By Katherine J. Wu & Katie Thomas